​

Hologic (HOLX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HOLX Stock Forecast

Hologic (HOLX) stock forecast, based on 38 Wall Street analysts, predicts a 12-month average price target of $87.00, with a high of $87.00 and a low of $87.00. This represents a 51.15% increase from the last price of $57.56.

$55 $62 $69 $76 $83 $90 High: $87 Avg: $87 Low: $87 Last Closed Price: $57.56

HOLX Stock Rating

Hologic stock's rating consensus is Buy, based on 38 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 21 Buy (55.26%), 16 Hold (42.11%), 1 Sell (2.63%), and 0 Strong Sell (0.00%).

Buy
Total 38 1 16 21 Strong Sell Sell Hold Buy Strong Buy

HOLX Price Target Upside V Benchmarks

TypeNameUpside
StockHologic51.15%
SectorHealthcare Stocks 35.25%
IndustryMedical Instruments & Supplies Stocks34.02%

Price Target Trends

1M3M12M
# Anlaysts--7
Avg Price Target--$79.43
Last Closing Price$57.56$57.56$57.56
Upside/Downside--38.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 254314--21
Mar, 253415--22
Feb, 254512--21
Jan, 254512--21
Dec, 245512-123
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2024Anthony PetroneMizuho Securities$87.00$78.8010.41%51.15%
Oct 04, 2024Anthony PetroneMizuho Securities$90.00$79.6313.02%56.36%
Oct 01, 2024Patrick DonnellyCitigroup$85.00$81.464.35%47.67%
Jul 30, 2024Mike MatsonNeedham$90.00$80.8411.33%56.36%
Jul 02, 2024Vijay KumarEvercore ISI$76.00$74.102.56%32.04%
Jun 27, 2024Ian ZaffinoOppenheimer$33.00$73.07-54.84%-42.67%
May 09, 2024David ToungArgus Research$95.00$75.8625.23%65.05%
Feb 02, 2023Cowen & Co.$95.00$83.7713.41%65.05%
Jan 10, 2023Wells Fargo$80.00$81.07-1.32%38.99%
Dec 07, 2022RBC Capital$75.00$74.221.05%30.30%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 14, 2024NeedhamBuyBuyhold
Oct 14, 2024William BlairCautiousCautioushold
Oct 04, 2024StephensSector PerformSector Performhold
Oct 01, 2024Evercore ISIPositivePositivehold
Oct 01, 2024CitigroupBuyNeutraldowngrade
Sep 17, 2024NeedhamBuyBuyhold
Jul 30, 2024NeedhamBuyBuyhold
Jul 30, 2024StephensSector PerformSector Performhold
Jul 30, 2024BTIGNeutralNeutralhold
Jul 30, 2024RBC CapitalSector PerformSector Performhold

Financial Forecast

EPS Forecast

$1 $2 $3 $4 $5 $6 $7 $8 Sep 20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$4.24$7.28$5.18$1.85$3.35-----
Avg Forecast$3.14$7.80$3.49$3.91$4.08$4.26$4.68$5.17$5.67$5.90
High Forecast$3.22$8.00$4.18$3.95$4.09$4.29$4.77$5.59$5.74$5.97
Low Forecast$3.06$7.60$2.79$3.78$3.96$4.23$4.57$4.30$5.49$5.71
Surprise %35.03%-6.67%48.42%-52.69%-17.89%-----

Revenue Forecast

$3B $4B $4B $5B $5B $6B Sep 20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$3.78B$5.63B$4.86B$4.03B$4.03B-----
Avg Forecast$3.54B$5.35B$4.51B$4.03B$4.02B$4.16B$4.40B$4.67B$5.00B$5.15B
High Forecast$3.61B$5.45B$5.41B$4.06B$4.06B$4.17B$4.44B$4.68B$5.04B$5.20B
Low Forecast$3.47B$5.24B$3.61B$4.02B$3.92B$4.15B$4.36B$4.66B$4.88B$5.03B
Surprise %6.71%5.33%7.82%0.13%0.27%-----

Net Income Forecast

$0 $400M $800M $1B $2B $2B Sep 20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported$1.12B$1.87B$1.30B$456.00M$789.50M-----
Avg Forecast$1.01B$1.46B$1.16B$515.10M$956.11M$1.01B$1.11B$1.17B$1.35B$1.40B
High Forecast$1.21B$1.76B$1.39B$618.12M$972.57M$1.02B$1.13B$1.33B$1.36B$1.42B
Low Forecast$804.65M$1.17B$925.83M$412.08M$939.64M$1.01B$1.09B$1.02B$1.31B$1.36B
Surprise %10.88%27.81%12.51%-11.47%-17.43%-----

HOLX Forecast FAQ

Is Hologic stock a buy?

Hologic stock has a consensus rating of Buy, based on 38 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 21 Buy, 16 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Hologic is a favorable investment for most analysts.

What is Hologic's price target?

Hologic's price target, set by 38 Wall Street analysts, averages $87 over the next 12 months. The price target range spans from $87 at the low end to $87 at the high end, suggesting a potential 51.15% change from the previous closing price of $57.56.

How does Hologic stock forecast compare to its benchmarks?

Hologic's stock forecast shows a 51.15% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical instruments & supplies stocks industry (34.02%).

What is the breakdown of analyst ratings for Hologic over the past three months?

  • April 2025: 19.05% Strong Buy, 14.29% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 13.64% Strong Buy, 18.18% Buy, 68.18% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 19.05% Strong Buy, 23.81% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.

What is Hologic’s EPS forecast?

Hologic's average annual EPS forecast for its fiscal year ending in September 2025 is $4.26, marking a 27.16% increase from the reported $3.35 in 2024. Estimates for the following years are $4.68 in 2026, $5.17 in 2027, $5.67 in 2028, and $5.9 in 2029.

What is Hologic’s revenue forecast?

Hologic's average annual revenue forecast for its fiscal year ending in September 2025 is $4.16B, reflecting a 3.29% increase from the reported $4.03B in 2024. The forecast for 2026 is $4.4B, followed by $4.67B for 2027, $5B for 2028, and $5.15B for 2029.

What is Hologic’s net income forecast?

Hologic's net income forecast for the fiscal year ending in September 2025 stands at $1.01B, representing an 28.21% increase from the reported $789.5M in 2024. Projections indicate $1.11B in 2026, $1.17B in 2027, $1.35B in 2028, and $1.4B in 2029.